Skip to Content

Betamethasone / Calcipotriene Topical Dosage

Medically reviewed by Drugs.com. Last updated on Jan 3, 2020.

Applies to the following strengths: 0.064%-0.005%

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Psoriasis

OINTMENT:
-Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
-The maximum weekly dose should not exceed 100 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

TOPICAL SUSPENSION:
-Apply to affected area(s) once daily for up to 8 weeks.
-The maximum weekly dose should not exceed 100 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

FOAM AEROSOL:
-Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
-Do not use more than 60 g every 4 days.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

Uses:
-Ointment formulation: For the topical treatment of plaque psoriasis in patients 12 years of age and older
-Topical suspension: For plaque psoriasis of the scalp and body in patients 18 years and older
-Foam aerosol: For the topical treatment of plaque psoriasis in patients 18 years of age and older

Usual Pediatric Dose for Psoriasis

OINTMENT:
12 years and older:
-Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
-The maximum weekly dose should not exceed 60 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

TOPICAL SUSPENSION:
12 years and older:
-Apply to affected area(s) once daily for up to 8 weeks.
-The maximum weekly dose should not exceed 60 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

Uses:
-Ointment formulation: For the topical treatment of plaque psoriasis in patients 12 years of age and older
-Topical suspension: For plaque psoriasis of the scalp in patients 12 to 17 years

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:
-None

Ointment and topical suspension formulations: Safety and efficacy have not been established in patients younger than 12 years.
Foam formulation: Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Rub product in gently and completely.
-Patients should wash their hands after application of the product.
-Avoid excessive exposure to either natural or artificial sunlight. Physicians may wish to limit or avoid use of phototherapy in such patients.
-Do not use this drug combination orally, ophthalmically, or intravaginally.
-Instruct patients to shake bottle prior to using the topical suspension or foam.

General:
This topical drug combination may cause eye irritation. Eye exposure should be avoided.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.